Readily available biomarkers predict poor survival in metastatic pancreatic cancer

CONCLUSIONS: In mPC patients, albumin, CA19-9, CRP, LDH, CRP/albumin ratio, and (m)GPS are prognostic for poor survival. Biomarkers did not predict response to chemotherapy. These readily available biomarkers can be used to better inform patients and to stratify in clinical trials.PMID:33663300 | DOI:10.1080/1354750X.2021.1893814

Source: Biomarkers - March 5, 2021 Category: Research Authors: Marin Strijker Eran van Veldhuisen Lydia G van der Geest Olivier R Busch Maarten F Bijlsma Nadia Haj Mohammad Marjolein Y Homs Jeanin E van Hooft Joanne Verheij Judith de Vos-Geelen Johanna W Wilmink Ewout W Steyerberg Marc G Besselink Hanneke W van Laarh Source Type: research